Glenmark receives ANDA approval for Dimethyl Fumarate Delayed-Release capsules EP News Bureau Oct 9, 2019 The drug is indicated to treat relapsing forms of multiple sclerosis Glenmark Pharmaceuticals has been granted tentative…
